Merrimack Reports Second Quarter 2017 Financial Results


This quarter s progress, with key hires to the executive team and advancements in the clinic, has reinforced Merrimack s refined corporate and clinical strategy. With a rich, biomarker-driven R&D pipeline, including data expected in 2018 for each of our lead assets – MM-121, MM-141 and MM-310 – and promising preclinical programs, we are well positioned to [ ] The post Merrimack Reports Second Quarter 2017 Financial Results appeared first on STL News.
http://bit.ly/2uoT7Ae

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s